CHC – The Cancer & Hematology Centers

In the News

As the largest physician-owned oncology and hematology practice in Michigan, we are often in the news. See what we've been up to.
CHCWM’s Dr. Yuanbin Chen – Journal of Thoracic Oncology

CHC’s Yuanbin Chen, MD is a contributing author in the Journal of Thoracic Oncology’s article “Durvalumab in Combination with Olaparib in Patients with Relapsed Small Cell Lung Cancer: Results from a Phase II Study”. Read the Article Read more »

CHCWM – START Midwest article in Yahoo Finance

CHC’s START Midwest program is in on another Phase I clinical trial making the news. Read the Article Read more »

Wendy Koopman article
CHCWM – Publication in the American Journal of Managed Care

CHC’s Wendy Koopman (Clinical Director and Nurse Practitioner), for her work on the Evidence Based Oncology – Adverse Event Tracking article, featured in the April 2019 issue of The American Journal of Managed Care. Read the Article Read more »

Journal of Clinical Oncology publication START Midwest
START Midwest – Publication in the Journal of Clinical Oncology

CHC’s Dr. Chandana, Dr. Lakhani, and Dr. O’Rourke, in their work with our START Midwest Phase I Clinical trials, are featured in the February 27, 2019 issue of The Journal of Clinical Oncology. Read the Study Read more »

Best and Brightest Companies to Work for in the nation 2018
CHCWM Wins 2018 Best and Brightest Companies to Work For in the Nation

Congratulations to the entire staff here at CHC! Awards like this are only possible because of the amazing people who work here. Your hard work and exceptional effort make this company what it is today! We look forward to bigger Read More »

CHCWM Laboratory microscope
CHCWM’s Lab & Eve Graham Featured in CAP Today Publication

CHC’s Director of Laboratory Services, Eve Graham, is featured in CAP Today’s Article “Advanced parameters offer faster, surer guidance to cancer care.”

“The general pattern, Dr. Hirsch-Ginsberg says, is that diagnostic tools often stay investigational for a long time before they’re as widely used as they could be. But she and Dr. Peerschke express confidence in the Sysmex advanced parameters’ robustness and Read More »

Page 11 of 11